Home

About

Advanced Search

Browse by Discipline

Scientific Societies

E-print Alerts

Add E-prints

E-print Network
FAQHELPSITE MAPCONTACT US


  Advanced Search  

 
Working with UCSB Corporate Affiliates Program was a natural evolution for CytomX Therapeutics, LLC since its foundational
 

Summary: Working with UCSB Corporate Affiliates Program was a natural
evolution for CytomX Therapeutics, LLC since its foundational
technologies evolved from research originally conducted at
UCSB.
CytomX (pronounced sigh-toe-mix)--an early-stage
biotherapeutics discovery company located in Goleta,
California-- was founded in February of 2008 when associate
professors Patrick Daugherty, Ph.D., Chemical Engineering and
Hyongsok (Tom) Soh, Ph.D., Mechanical Engineering combined
forces with UCSB Professor/Nobel Laureate in Chemistry (2000)
Alan Heeger, Ph.D., Physics and investor Frederick Gluck.
"The purpose behind the founding of CytomX was to design
biotherapeutics that selectively target sites of disease in the
body,"said Patrick Daugherty, Board member and acting Chief
Scientific Officer."Specifically, CytomX has a new technology
that will deliver Probodies TM, protease-activated antibody
therapeutics, and other biologics to specific locations in
the body." The therapeutics target and localize treatment
to diseased tissues, a process that avoids damaging healthy
tissues. Targeted treatment means more effective and safer

  

Source: Akhmedov, Azer - Department of Mathematics, University of California at Santa Barbara

 

Collections: Mathematics